These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26257235)

  • 1. Vision loss and vascular compromise with facial and periocular injections.
    Li B; Allen LH; Sheidow TG
    Can J Ophthalmol; 2015 Aug; 50(4):e57-60. PubMed ID: 26257235
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmic and Central Retinal Artery Occlusion Following Triamcinolone Injection of the Lacrimal Gland.
    Raufi NN; Wisely CE; Leyngold IM; Vajzovic L
    JAMA Ophthalmol; 2019 Dec; 137(12):1460-1461. PubMed ID: 31600385
    [No Abstract]   [Full Text] [Related]  

  • 3. Sneddon's syndrome with optic disc macroaneurysm and macular edema successfully treated with subtenon steroid injection.
    Nagai N; Ohta Y; Izumi-Nagai K; Shinoda H; Tsubota K; Ozawa Y
    Acta Ophthalmol; 2016 Sep; 94(6):e517-9. PubMed ID: 26612193
    [No Abstract]   [Full Text] [Related]  

  • 4. Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.
    Imasawa M; Ohshiro T; Gotoh T; Imai M; Iijima H
    Acta Ophthalmol Scand; 2005 Feb; 83(1):132-3. PubMed ID: 15715582
    [No Abstract]   [Full Text] [Related]  

  • 5. Myopathic ptosis following posterior sub-Tenon's triamcinolone acetonide injection.
    Morley AM; Tumuluri K; Meligonis G; Collin JR
    Eye (Lond); 2009 Mar; 23(3):741-2. PubMed ID: 18425066
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the editor regarding: "cystoid macular edema secondary to gyrate atrophy in a child treated with sub-tenon injection of triamcinolone acetonide".
    Elnahry AG
    Rom J Ophthalmol; 2018; 62(4):317-318. PubMed ID: 30891531
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
    Bae JH; Lee CS; Lee SC
    Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
    Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
    Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
    Er H
    Am J Ophthalmol; 2006 Oct; 142(4):710; author reply 710. PubMed ID: 17011888
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical dexamethasone γ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema.
    Ohira A; Hara K; Jóhannesson G; Tanito M; Ásgrímsdóttir GM; Lund SH; Loftsson T; Stefánsson E
    Acta Ophthalmol; 2015 Nov; 93(7):610-5. PubMed ID: 26201996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periocular triamcinolone acetonide as treatment for macular edema secondary to branch vein occlusion associated with retinal arteriovenous malformation.
    Federici T; Batlle I
    Retina; 2006; 26(9):1079-80. PubMed ID: 17151499
    [No Abstract]   [Full Text] [Related]  

  • 13. Moment of cyst eruption captured by optical coherence tomography in diabetic macular edema.
    Oh JH; Oh J
    Retina; 2015 Jun; 35(6):1283-4. PubMed ID: 25621946
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration.
    Larsson J; Gillies MC
    Clin Exp Ophthalmol; 2005 Oct; 33(5):544-5. PubMed ID: 16181292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema.
    Yalcinbayir O; Gelisken O; Kaderli B; Avci R
    Ophthalmologica; 2011; 225(4):222-7. PubMed ID: 21389739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correspondence.
    Lorenzo-Carrero J
    Retina; 2009 Jun; 29(6):868-9; author reply 869. PubMed ID: 19516126
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
    Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
    Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema.
    Kim HD; Kang KD; Choi KS; Rhee MR; Lee SJ
    Acta Ophthalmol; 2014 Nov; 92(7):e589-90. PubMed ID: 24866832
    [No Abstract]   [Full Text] [Related]  

  • 20. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.